Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05373719 · ClinicalTrials.gov registry record
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
A clinical trial of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder, sponsored by Loulou Foundation.
- Active
- Registry status
- 112
- Enrollment target
- 20
- Study locations
NCT05373719: Active study of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder, sponsored by Loulou Foundation.
NCT05373719 is a study of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder that is active but no longer recruiting, run by Loulou Foundation. The registered enrollment target is 112 participants. The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05373719, a study of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder, is active but no longer recruiting, sponsored by Loulou Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- 112 participants
- Enrollment target
- 20
- Study locations
Study Summary
Observational, noninterventional, 3-year study to examine the presence of detectable differences in neurocognitive, developmental, motor, neurophysiologic, and quality of life measures over time in patients with cyclin-dependent kinase-like 5 deficiency disorder.
Primary Outcome
Suitability of this cognition and global development scale in CDD will be assessed based on the number of tests completed, ceiling/floor effect and variance estimate.
Conditions Studied
Interventions
- OTHER No intervention; observational
Study Locations (20)
Other
- Alberta Children's Hospital, Pediatric Epilepsy and Child Neurology - Calgary
- The Hospital of Sick Children - Toronto
- Hopital Necker- Enfants Malades - Paris
- DRK Berlin - Epilepsiezentrum und Neuropädiatrie - Berlin
- Schön Klinik Vogtareuth - Vogtareuth
- Azienda Ospedaliero-Universitaria Meyer - Florence
- Fondazione Policlinico Universitario A Gemelli, IRCCS - Roma
- Ospedale Pediatrico Bambino Gesù - Rome
- Azienda Ospedaliera Universitaria Integrata di Verona - Verona
- Hospital Infantil Universitario Niño Jesús - Madrid
- Ruber Internacional Hospital - Madrid
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- The Cleveland Clinic - Cleveland
California
- UCLA Mattel Children's Hospital - Los Angeles
Colorado
- Children's Hospital Colorado - Aurora
Georgia
- Center for Rare Neurological Diseases - Norcross
Massachusetts
- Boston Children's Hospital - Boston
New York
- New York University - New York
Pennsylvania
- Childrens Hospital of Philadlephia Division of Neurology - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2027-01-20 |
What the registry record for NCT05373719 still lists
NCT05373719 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder appearing as the primary indexed condition, and to 1 intervention - of which No intervention; observational is the first listed.
NCT05373719 names 20 study sites across 9 states, led by Other, Ohio, California.
Frequently Asked Questions
What is clinical trial NCT05373719 about?
NCT05373719 is a clinical study titled "Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder". Observational, noninterventional, 3-year study to examine the presence of detectable differences in neurocognitive, developmental, motor, neurophysiologic, and quality of life measures over time in patients with cyclin-dependent kinase-like 5 deficiency disorder.
What is the current status of trial NCT05373719?
This trial is currently active not recruiting. The enrollment target is 112 participants. The study started on 2022-09-30. Estimated completion is 2027-01-20.
What conditions does trial NCT05373719 study?
This clinical trial studies the following conditions: Cyclin-Dependent Kinase-Like 5 Deficiency Disorder.
What interventions are being tested in trial NCT05373719?
The interventions under investigation include: No intervention; observational (OTHER).
Who is sponsoring clinical trial NCT05373719?
This trial is sponsored by Loulou Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05373719 being conducted?
This trial has 20 study locations across California, Colorado, Georgia, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI